The primary findings were that high Lp(a) levels were related to increased MACE risk and very high Lp(a) levels (≥ 50 mg/dL) significantly indicated poor outcomes in patients with DM, while not in those without DM. This evidence concerns the gene LPA and diabetes mellitus.